-
Je něco špatně v tomto záznamu ?
Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls
L. Micenková, L. Frankovičová, I. Jaborníková, J. Bosák, P. Dítě, J. Šmarda, M. Vrba, A. Ševčíková, M. Kmeťová, D. Šmajs,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
- MeSH
- bakteriální toxiny genetika MeSH
- bakteriociny metabolismus MeSH
- Crohnova nemoc mikrobiologie MeSH
- Escherichia coli genetika izolace a purifikace metabolismus MeSH
- extraintestinální patogenní Escherichia coli izolace a purifikace patogenita MeSH
- lidé MeSH
- lyasy oxokyselin genetika MeSH
- proteiny fimbrií genetika MeSH
- proteiny z Escherichia coli genetika MeSH
- pulzní gelová elektroforéza MeSH
- střevní mikroflóra fyziologie MeSH
- ulcerózní kolitida mikrobiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
A set of 178 Escherichia coli isolates taken from patients with inflammatory bowel disease (IBD) was analyzed for bacteriocin production and tested for the prevalence of 30 bacteriocin and 22 virulence factor determinants. Additionally, E. coli phylogenetic groups were also determined. Pulsed-field gel electrophoresis (PFGE) was used for exclusion of clonal character of isolates. Results were compared to data from a previously published analysis of 1283 fecal commensal E. coli isolates. The frequency of bacteriocinogenic isolates (66.9%) was significantly higher in IBD E. coli compared to fecal commensal E. coli isolates (54.2%, p < 0.01). In the group of IBD E. coli isolates, a higher prevalence of determinants for group B colicins (i.e., colicins B, D, Ia, Ib, M, and 5/10) (p < 0.01), including a higher prevalence of the colicin B determinant (p < 0.01) was found. Virulence factor determinants encoding fimbriae (fimA, 91.0%; pap, 27.5%), cytotoxic necrotizing factor (cnf1, 11.2%), aerobactin synthesis (aer, 43.3%), and the locus associated with invasivity (ial, 9.0%) were more prevalent in IBD E. coli (p < 0.05 for all five determinants). E. coli isolates from IBD mucosal biopsies were more frequently bacteriocinogenic (84.6%, p < 0.01) compared to fecal IBD isolates and fecal commensal E. coli. PFGE analysis revealed clusters specific for IBD E. coli isolates (n = 11), for fecal isolates (n = 13), and clusters containing both IBD and fecal isolates (n = 10). ExPEC (Extraintestinal Pathogenic E. coli) virulence and colicin determinants appear to be important characteristics of IBD E. coli isolates, especially the E. coli isolates obtained directly from biopsy samples.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000758
- 003
- CZ-PrNML
- 005
- 20190121101559.0
- 007
- ta
- 008
- 190107s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijmm.2018.04.008 $2 doi
- 035 __
- $a (PubMed)29735381
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Micenková, Lenka $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic; Research Centre for Toxic Compounds in the Environment, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
- 245 10
- $a Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls / $c L. Micenková, L. Frankovičová, I. Jaborníková, J. Bosák, P. Dítě, J. Šmarda, M. Vrba, A. Ševčíková, M. Kmeťová, D. Šmajs,
- 520 9_
- $a A set of 178 Escherichia coli isolates taken from patients with inflammatory bowel disease (IBD) was analyzed for bacteriocin production and tested for the prevalence of 30 bacteriocin and 22 virulence factor determinants. Additionally, E. coli phylogenetic groups were also determined. Pulsed-field gel electrophoresis (PFGE) was used for exclusion of clonal character of isolates. Results were compared to data from a previously published analysis of 1283 fecal commensal E. coli isolates. The frequency of bacteriocinogenic isolates (66.9%) was significantly higher in IBD E. coli compared to fecal commensal E. coli isolates (54.2%, p < 0.01). In the group of IBD E. coli isolates, a higher prevalence of determinants for group B colicins (i.e., colicins B, D, Ia, Ib, M, and 5/10) (p < 0.01), including a higher prevalence of the colicin B determinant (p < 0.01) was found. Virulence factor determinants encoding fimbriae (fimA, 91.0%; pap, 27.5%), cytotoxic necrotizing factor (cnf1, 11.2%), aerobactin synthesis (aer, 43.3%), and the locus associated with invasivity (ial, 9.0%) were more prevalent in IBD E. coli (p < 0.05 for all five determinants). E. coli isolates from IBD mucosal biopsies were more frequently bacteriocinogenic (84.6%, p < 0.01) compared to fecal IBD isolates and fecal commensal E. coli. PFGE analysis revealed clusters specific for IBD E. coli isolates (n = 11), for fecal isolates (n = 13), and clusters containing both IBD and fecal isolates (n = 10). ExPEC (Extraintestinal Pathogenic E. coli) virulence and colicin determinants appear to be important characteristics of IBD E. coli isolates, especially the E. coli isolates obtained directly from biopsy samples.
- 650 _2
- $a bakteriální toxiny $x genetika $7 D001427
- 650 _2
- $a bakteriociny $x metabolismus $7 D001430
- 650 _2
- $a ulcerózní kolitida $x mikrobiologie $7 D003093
- 650 _2
- $a Crohnova nemoc $x mikrobiologie $7 D003424
- 650 _2
- $a pulzní gelová elektroforéza $7 D016521
- 650 _2
- $a Escherichia coli $x genetika $x izolace a purifikace $x metabolismus $7 D004926
- 650 _2
- $a proteiny z Escherichia coli $x genetika $7 D029968
- 650 _2
- $a extraintestinální patogenní Escherichia coli $x izolace a purifikace $x patogenita $7 D000072282
- 650 _2
- $a proteiny fimbrií $x genetika $7 D036781
- 650 _2
- $a střevní mikroflóra $x fyziologie $7 D000069196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lyasy oxokyselin $x genetika $7 D007652
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Frankovičová, Lucia $u Department of Medical Microbiology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, 040 11, Košice, Slovak Republic.
- 700 1_
- $a Jaborníková, Iva $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 700 1_
- $a Bosák, Juraj $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 700 1_
- $a Dítě, Petr $u Internal Department of Gastroenterology, Faculty of Medicine, Masaryk University, Jihlavská 20, 639 00, Brno, Czech Republic; Academic Center of Gastroenterology, Department of Internal Medicine, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, 708 52 Ostrava, Czech Republic.
- 700 1_
- $a Šmarda, Jan $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 700 1_
- $a Vrba, Martin $u Department of Clinical Microbiology, Faculty Hospital Brno, Jihlavská 20, 625 00, Brno, Czech Republic.
- 700 1_
- $a Ševčíková, Alena $u Department of Clinical Microbiology, Faculty Hospital Brno, Jihlavská 20, 625 00, Brno, Czech Republic.
- 700 1_
- $a Kmeťová, Marta $u Department of Medical Microbiology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, 040 11, Košice, Slovak Republic.
- 700 1_
- $a Šmajs, David $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic. Electronic address: dsmajs@med.muni.cz.
- 773 0_
- $w MED00005699 $t International journal of medical microbiology IJMM $x 1618-0607 $g Roč. 308, č. 5 (2018), s. 498-504
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29735381 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190121101817 $b ABA008
- 999 __
- $a ok $b bmc $g 1364770 $s 1038881
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 308 $c 5 $d 498-504 $e 20180501 $i 1618-0607 $m International journal of medical microbiology $n Int J Med Microbiol $x MED00005699
- LZP __
- $a Pubmed-20190107